| NCT ID | NCT05386719 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 450 participants |
| Start Date | 2022-06-03 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 450 participants in total. It began in 2022-06-03 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and/or hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. This program will also help to direct individuals with risk factors to community and institutional resources for management.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of early stage breast cancer * Completed local and/or systemic therapy at least 3 months ago * Receiving medical oncology care at through the breast cancer clinics at Johns Hopkins Medical Institute, including the Sidney Kimmel Comprehensive Cancer Center in Baltimore MD and Green Spring Station in Lutherville-Timonium MD, and Sibley Memorial Hospital in Washington D.C. * Read and speak English Exclusion Criteria: * Metastatic breast cancer
Contact & Investigator
Jennifer Sheng, M.D.
PRINCIPAL INVESTIGATOR
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Frequently Asked Questions
Who can join the NCT05386719 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05386719 currently recruiting?
Yes, NCT05386719 is actively recruiting participants. Contact the research team at HopkinsBreastTrials@jhmi.edu for enrollment information.
Where is the NCT05386719 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT05386719 clinical trial?
NCT05386719 is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The principal investigator is Jennifer Sheng, M.D. at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The trial plans to enroll 450 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.